increased in the unconscious patients. The mean arterial-venous Pco2 difference was normal in conscious patients but significantly reduced in the unconconscious patientsin this latter group the mean Pco2 difference between CSF and jugular venous blood was significantly elevated. They concluded that CSF acidosis, present in unconscious patients, both in lumbar and ventricular fluid, is associated with low bicarbonate and relatively high Pco2 values due to acid metabolites and co2 production. The suggestion is that the primary disturbance is a cerebral metabolic acidosis caused by the brain lesion and that the hyperventilation is a secondary compensation mechanism to restore normal intracranial pH. The CSF pH, however, is only correctable by relatively high levels of ventilation, and they suggest that these patients should be artificially ventilated to relieve the respiratory work load, and that the CSF acid-base status is probably a better guide than blood acid-base status for the setting of a mechanical ventilator. However, this view is not generally supported; Froman reported on 2 patients in 1968 and suggested that lowering of the arterial Pco2 had an adverse effect on the patients, presumably by the concomitant reduction in cerebral blood flow.
A criticism which can be levelled against the work already mentioned is that comparisons are often made between measurements which are grossly separated in time, and that the intracranial pathology is often mixed. There appear to be no 'follow through' types of study. In a modest pilot trial at Oxford we have tried to follow the time course of events in patients who have received severe head injuries. These patients had an average age of 33 years and all were ventilating spontaneously, in most cases via an endotracheal tube or tracheostomy. It was not considered wise to take CSF samples, so our attention was concentrated on the ventilation and acid-base status in arterial blood. Thirty patients were studied over a 12-month period; 10 patients (33%) died within 3 days; the total deaths were 16 (53 %), the mean survival time being 6-2 days and the median 3 days; some of these patients had other injuries, such as injuries to limbs, and 7 had a mild chest injury; this was not thought to complicate the picture unduly as the percentage venous admixture breathing oxygen was not significantly different from that breathing room air. Hyperventilation was seen only on the day of injury and the succeeding day; thereafter the minute volume settled at about 8 1./min with Paco, values within normal limits. The mean Pao2 on the day of admission was 64 4 mmHg (s.d. 17-9 mmHg). A low arterial pH (mean 7-413) was seen only on the day of injury, thereafter being abnormally raised for the next 11 days of study; this was associated with a nonrespiratory alkalosis of 3 to 5 mEq/litre base excess from the second to the eleventh day following injury. The reason for this finding is not clear; serum chloride, sodium and potassium levels were within normal limits and the effect was not due to the transfusion of stored blood. It is suggested that future studies should include a full metabolic balance and a comprehensive report of our findings will be presented elsewhere (Rucklidge et al., in preparation.) 4cknowledgments: We wish to thank Mr J Pennybacker and Mr J M Potter for their assistance in studying patients under their care. 
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Management of Coagulation Disturbances
The problems in the intensive care of the patient who bleeds abnormally differ very little from those encountered in everyday hospital practice. The main rule is to define the defect and treat accordingly. In this situation, normal results are just as informative as abnormal.
In any situation, provided the patient is conscious, a careful history of previous episodes of bleeding in the patient and his family may provide information relating to the likelihood and severity and type of an inherited defect. In the unconscious patient, or where there is an acquired defect, such information may be unobtainable or of no value. Many different inherited and acquired defects are now recognized and are described in textbooks of hwmatology.
Two points must be emphasized: first, the bleeding and clotting times are by themselves useless investigations. Further, there is no single screening test for all defects. Where abnormal bleeding occurs, some twelve or more tests have to be performed in order to exclude all known inherited or acquired defects. Thus, there is no alternative but to seek help from the haematology department as quickly as possible and, if possible, before a blood transfusion is given. This can invalidate results and by itself produce borderline abnormalities which are difficult to evaluate.
Preoperative screening of platelet and coagulation function is controversial, yet it would appear to be worthwhile to check the blood prior to major surgery, e.g. cardiac surgery, when the expected incidence of postoperative bleeding is increased. Preoperative normality allows a more intelligent appreciation of the results of tests in the postoperative and posttransfusion situation.
Massive blood transfusion in a period of 1-5 hours involving a complete blood volume replacement can itself produce an increased tendency to bleed. The so-called 'dilution syndrome' is the consequence of reducing the number of platelets and certain coagulation factors to levels which are inadequate for hmmostasis in a situation where the latter mechanism is stressed. When this occurs, there is no alternative but to use fresh whole blood for further transfusion. Further, neutralization of citrate by calcium gluconate is essenwial in such massive transfusions.
Occasionally, excess systemic or local fibrinolytic activity may be the cause of abnormal bleeding. The fibrinolytic mechanism exists to remove excess fibrin from the vessels or tissues, but in rare situations the mechanism can overreact and enhance bleeding from already damaged tissue, e.g. the prostatic cavity or brain meninges.
There is increasing awareness that in many diverse clinical syndromes the clinical state is produced or complicated by an episode of diffuse intravascular coagulation (DIC) which can, at the same time, produce intravascular microthrombi and depletion of platelets and coagulation factors leading to excessive hemorrhage. The number of syndromes where DIC can develop is increasing. They can, however, be classfied into: (1) Those where there is a massive release of tissue thromboplastin into the circulation, e.g. abruptio placenta or trauma. (2) Endotoxemia as a result of various bacterial infections with and without septicwmia, e.g. staphylococcal pneumonia and E. coli septicnmia. (3) Antigen antibody reactions, e.g. in tissue transplantations and virus infections.
The definitive management of the problem of abnormal bleeding lies first in defining the exact defect or defects by the laboratory. Once the defect is defined, then specific replacement therapy can be given in amounts depending on the severity and nature of the defect. Where DIC has occurred and this can be implicated as a complication or cause of a given clinical state, then anticoagulant therapy with heparin or fibrinolytic therapy depends on the circumstances of the individual case and no definitive guide-lines can be laid down. In three situations there is good reason to believe heparin therapy may be lifesaving: amniotic fluid embolism, incompatible transfusion reaction and purpura fulminans or gangrenosa.
Antifibrinolytic therapy by aminocaproic acid, Epsikapron or aprotinin (Trasylol) is seldom indicated in the treatment of abnormal bleeding and, even where the use of these drugs may appear to be reasonable, their effect may lead to dangerous fibrin deposition. The main use for these drugs lies in the reversal of activator effect during fibrinolytic the'rapy with streptokinase or urokinase.
Dr J G B Thurston ( Westminster Hospital, London SWI)
Place of Hyperbaric Oxygen in intensive Care
Hyperbaric oxygen is oxygen at a pressure greater than atmospheric pressure. It may be given to the patient in a single patient chamber filled with oxygen, or in a large walk-in chamber, where the patient and attendants are compressed in air and the patient breathes oxygen by face mask.
In air at atmospheric pressure, assuming a normal hlmoglobin level, 19-4 ml oxygen are carried in every 100 ml blood. In addition to this, 0 3 ml oxygen are physically dissolved in the plasma. It is this latter figure which is increased when the patient is subjected to hyperbaric pressures. Clearly the oxyheemoglobin level cannot be increased once the haemoglobin is fully saturated with oxygen. Thus, at 1 atmosphere of pure oxygen the dissolved oxygen rises to 20 ml, at 2 atmospheres of pressure it is 4-3 ml and at 3 atmospheres 6-5 ml. In the resting state, the tissues use about 6 ml oxygen from every 100 ml blood passing through. At 3 atmospheres of pure oxygen, therefore, hemoglobin becomes superfluous. This was confirmed by Boerema et al. (1960) Hyperbaric oxygen has been used in practically every branch of medicine. The absolute indications for its use arc air embolism, gas gangrene, carbon monoxide poisoning and the bends. The last is only seen in caisson workers or in deep sea divers and does not come within the ambit
